FDA Inspection
Garonit Pharmaceutical, Inc.Garonit Pharmaceutical, Inc. – FDA Inspection, Jul 6, 2023
Record Details
This FDA Inspection record concerns Garonit Pharmaceutical, Inc., with an inspection on July 6, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3b9dea3b-2bcd-4786-88f5-dfb816ee2dc5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1209320
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Garonit Pharmaceutical, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| January 14, 2020 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| November 28, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 26, 2016 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| January 31, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Garonit Pharmaceutical, Inc.
- FDA Inspection 1116449 - 2020-01-14
- FDA Inspection 1035090 - 2017-11-28
- FDA Inspection 986872 - 2016-08-26
- FDA Inspection 864565 - 2014-01-31
- FDA Inspection 718283 - 2011-04-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.